17.81 USD
↘ 0.09 (0.50%)PRE MARKET (AS OF 06:45 AM EDT)
Dyne Therapeutics, Inc. Common Stock
DYNNASDAQ • USD
Market: OPEN
Shares of Dyne Therapeutics, Inc. Common Stock (DYN) are trading at $17.81. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. DYN is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Sep 15, 2026.
Open?$17.89
High?$17.89
Low?$17.81
Prev. Close?$17.90
Volume?540
Avg. Volume?2.6M
VWAP?$17.89
Rel. Volume?0.00x
Bid / Ask
Bid?$15.54 × 100
Ask?$21.22 × 100
Spread?$5.68
Midpoint?$18.38
Valuation & Ratios
Market Cap?3.3B
Shares Out?186.7M
Float?167.9M
Float %?89.9%
P/E Ratio?N/A
P/B Ratio?4.76
EPS?-$2.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Themes
Address
1560 TRAPELO ROAD
WALTHAM, MA 02451
Phone: (781) 786-8230
WALTHAM, MA 02451
Phone: (781) 786-8230
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?88
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?3.74Safe
Confidence?52%Low
Short InterestVery High
Short % of Float?12.38%High
Short Interest?20.8M
Days to Cover?13.5
Free Float167.9M
Avg Daily Volume1.5M
Settlement Date2026-08-31
Financial Health
Current Ratio?12.02Strong
Quick Ratio?12.02Strong
Cash Ratio?8.66Strong
Debt/Equity?0.30Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.76FAIR▾
Peers100
S&P38
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-74.0%WEAK▾
S&P3
ROA?-52.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-499223000
Enterprise Value?$2.9B
Fundamentals ratios updated end of day